from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3664c/dppC

LFCtreatmentdescriptionclass of inhibitor

0.071

Amikacinug/mL Amikacintranslation

0.290

Cap5-10ug/mL Capreomycintranslation

0.037

Rox10-50 ug/mL Roxithromycintranslation

1.172

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.841

Rif0.2-5ug/mL Rifampicintranscription

0.354

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.327

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.596

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.062

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.159

Clofazimine10-13 ug/mL Clofaziminerespiration

0.345

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.358

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.033

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.531

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.949

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.646

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.178

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.078

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.712

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.289

Nigericin50 uM Nigericinrespiration

0.166

TRC10-150 ug/mL Triclosanrespiration

-0.390

TRZ10-25 ug/mL Thioridazinerespiration

-1.271

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.706

menadione6-10 ug/mL Menadionerespiration

-0.131

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.264

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.357

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.190

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.588

NRP_1Non-replicating persistence stage 1dosRassociated

0.539

Amp0.2mg/mL AmpicillincellWall

-0.382

Cephalexin20-100 ug/mL CephalexincellWall

1.077

Cerulenin0.32-5 ug/mL CerulenincellWall

0.996

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.476

EMB10-20 ug/mL EthambutolcellWall

-0.195

Eta12-40 ug/mL EthionamidecellWall

-0.227

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.094

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.315

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.238

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.578

BZA0.12 mg/mL BenzamidearomaticAmides

-0.072

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.176

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.716

H2O24 mM hydrogen peroxideDNAdamaging

-0.048

Levo10 ug/mL LevofloxacinDNAdamaging

0.322

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.404

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.531

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.381

UVUV-irradiationDNAdamaging

-0.961

ARP41-4 ug/mL Antitubercular compound ARP4?

0.241

Antimycin12.5-50 ug/mL Antimycin A?

-0.375

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.090

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.497

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.545

PA8240.2-2 ug/mL PA-824?

-0.871

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.223

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.389

Verapamil50 uM Verapamil?

-0.464

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.485

methoxatin10-20 ug/mL Methoxatin?